Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects

PURPOSE: Rolapitant is a neurokinin-1 receptor antagonist indicated in combination with other antiemetic agents in adults for the prevention of delayed chemotherapy-induced nausea and vomiting. We evaluated the effects of rolapitant oral on the pharmacokinetics of probe substrates for cytochrome P45...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Zhang, Zhi-Yi, Lu, Sharon, Powers, Dan, Kansra, Vikram, Wang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373243/
https://www.ncbi.nlm.nih.gov/pubmed/30084103
http://dx.doi.org/10.1007/s00520-018-4331-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373243/
https://www.ncbi.nlm.nih.gov/pubmed/30084103
http://dx.doi.org/10.1007/s00520-018-4331-x

Ejemplares similares